PDD to Present on Pharmacodynamic Biomarkers at GTCbio’s Rediscovering Biomarkers: Detection, Development & Validation Conference - July 23-24, 2007, San Diego, CA
Monrovia, CA, June 23, 2007 --(PR.com)-- Dr. Aaron B. Kantor, Executive Director of Cell and Molecular Biology, Biomarker Discovery Sciences at PPD, Inc. will present on Pharmacodynamic Biomarkers Identified with Broad-Based Phenotyping at GTCbio’s Rediscovering Biomarkers: Detection, Development & Validation Conference taking place on July 23-24, 2007 at the San Diego Marriott La Jolla in La Jolla, CA.
Broad-based phenotyping provides fundamental information about disease and treatment and enables discovery of new and useful biomarkers. We applied SurroScanTM laser scanning cytometry, immunoassays for specific soluble proteins, and mass-spectrometry based differential proteomics which track thousands of analytical variables, to the identification of pharmacodynamic markers for interferon-1-beta in multiple sclerosis subjects. A strong pharmacodynamic effect was observed 1.5 vs. 6 days post weekly drug injection. Significant differences included interferon- inducible gene products, and monocyte-associated variables. Multiple differences were also observed among multiple sclerosis and healthy control cohorts.
GTCbio’s Rediscovering Biomarkers: Detection, Development & Validation Conference provides comprehensive coverage of a wide range of topics including Biomarker Application in Oncology Clinical Development, Drug Discovery, Development and Diagnostics of Biomarkers, Tools for Improving Measurement, Safety and Validation of Biomarkers, and Upcoming Technology and Trends.
For more information including a detailed agenda, exhibitor opportunities and registration information visit http://www.gtcbio.com/conference/conferenceDetails.aspx?id=101
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, raniah@gtcbio.com
###
Broad-based phenotyping provides fundamental information about disease and treatment and enables discovery of new and useful biomarkers. We applied SurroScanTM laser scanning cytometry, immunoassays for specific soluble proteins, and mass-spectrometry based differential proteomics which track thousands of analytical variables, to the identification of pharmacodynamic markers for interferon-1-beta in multiple sclerosis subjects. A strong pharmacodynamic effect was observed 1.5 vs. 6 days post weekly drug injection. Significant differences included interferon- inducible gene products, and monocyte-associated variables. Multiple differences were also observed among multiple sclerosis and healthy control cohorts.
GTCbio’s Rediscovering Biomarkers: Detection, Development & Validation Conference provides comprehensive coverage of a wide range of topics including Biomarker Application in Oncology Clinical Development, Drug Discovery, Development and Diagnostics of Biomarkers, Tools for Improving Measurement, Safety and Validation of Biomarkers, and Upcoming Technology and Trends.
For more information including a detailed agenda, exhibitor opportunities and registration information visit http://www.gtcbio.com/conference/conferenceDetails.aspx?id=101
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, raniah@gtcbio.com
###
Contact
GTCbio
Rania Hafez
626-256-6405
www.gtcbio.com
Rania Hafez
626-256-6405
www.gtcbio.com
Contact
Categories